Class / Patent application number | Description | Number of patent applications / Date published |
536005000 | Cyclopentanohydrophenanthrene ring system | 30 |
20090012277 | Process for Preparation of Timosaponin B II - A method for preparation of Timosaponin BII, which uses Chinese traditional medicine Rhizoma Anemarrhenae or fresh rhizoma or fibrous root of | 01-08-2009 |
20100056767 | SELECTIVE SEPARATION OR EXTRACTION OF STEROIDAL GLYCOSIDES BY SUPERCRITICAL FLUID EXTRACTION USING CARBON DIOXIDE - A method for selectively separating desirable steroidal glycosides from undesirable components present in plant material of the Asclepiadaceae family containing the same. The method comprises contacting the plant material or material derived therefrom (herein: “the material”) with liquid or supercritical carbon dioxide under conditions whereby the desirable steroidal glycosides dissolve in the liquid or supercritical carbon dioxide in preference to the undesirable components, and subsequently recovering the desirable steroidal glycosides from the carbon dioxide solution. | 03-04-2010 |
20100168406 | USE OF GINSENOSIDE Rb2 MONOMER IN THE MANUFACTURE OF MEDICAMENTS FOR THROMBOLYSIS - The present invention discloses use of ginsenoside Rb | 07-01-2010 |
20100204460 | NATURAL BRASSINOSTEROIDS FOR USE FOR TREATING HYPERPROLIFERATION, TREATING PROLIFERATIVE DISEASES AND REDUCING ADVERSE EFFECTS OF STEROID DYSFUNCTION IN MAMMALS, PHARMACEUTICAL COMPOSITION AND ITS USE - The present invention relates to natural brassinosteroids of general formula (I), wherein R is CH | 08-12-2010 |
20110054155 | Novel Environmentally Friendly Technology for Production of Ginsenoside Re - This invention relates to a technology used for a fast separation of Ginsenoside Re directly from other ginsensosides with similar molecular structures. In a conventional method, multiple steps and complex organic mobile phases are required to obtain a highly purified Ginsenoside Re compound, which are time consuming and organic solvent consumption, an obstacle for large scale industrial production. In our new technology, a quick separation for a mixture of two compounds with similar molecular structure. Ginsenoside Re and Ginsenoside Rg1 was demonstrated through a Surpass™ PolyGin-Re column 2×250 mm, in which only methanol was used for elution, no acids or bases were needed, which could be a Green technology for Ginsenoside Re production in the future. | 03-03-2011 |
20110166334 | ANTIBACTERIAL 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS HAVING MULTIPLE SUBSTITUENTS - The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection. | 07-07-2011 |
20110251378 | ONE-POT SYNTHESIS OF ALPHA/BETA-O-GLYCOLIPIDS - The present invention provides a one-pot method of preparing an unprotected α-O-glycolipid. The first step involves contacting a protected α-iodo sugar with a catalyst and a lipid comprising a hydroxy group, under conditions sufficient to prepare a protected α-O-glycolipid. The second step involves deprotecting the protected α-O-glycolipid under conditions sufficient to prepare the unprotected α-O-glycolipid, wherein the contacting and deprotecting steps are performed in a single vessel. The present invention also provides a one-pot method of preparing an unprotected β-O-glycolipid following the steps for the preparation of the unprotected α-O-glycolipid. | 10-13-2011 |
20140039170 | COMPOSITION FOR TOPICAL SKIN APPLICATION CONTAINING GINSENOSIDE F2 DERIVED FROM HYDROPONIC GINSENG - Beneficial effects are obtained by topically applying ginsenoside F2 to the skin to improve skin conditions, improve water content on the skin surface and related benefits improving skin problems associated with acne or atopy, providing a skin whitening effect, helping control of sebaceous secretion, tightening skin pores, or improving skin complexion through enhanced blood circulation, but also to improve scalp and hair conditions, such as providing an anti-dandruff effect, promoting hair growth, or preventing generation of grey hair. | 02-06-2014 |
20140058074 | USE OF 3,8,12,14, 17,20-OXO-SUBSTITUTED PREGNENE GLYCOSIDES IN THE PREPARATION OF HEALTHCARE PRODUCTS, FOOD ADDITIVES AND PHARMACEUTICALS FOR THE INHIBITION OF APPETITE - The present invention relates to the use of 3,8,12,14,17,20-oxo-substituted pregnene glycosides having the following formula I in the preparation of healthcare products, food additives and drugs for losing body weight, controlling body weight and inhibiting appetite of human beings or animals, wherein, R | 02-27-2014 |
20140128582 | CONTINUOUS PREPARATION METHOD OF GINSENG GINSENOSIDES AND POLYSACCHARIDES - The present invention provides a continuous preparation method of | 05-08-2014 |
20140221633 | ONE-POT SYNTHESIS OF ALPHA/BETA-O-CLYCOLIPIDS - The present invention provides a one-pot method of preparing an unprotected α-O-glycolipid. The first step involves contacting a protected α-iodo sugar with a catalyst and a lipid comprising a hydroxy group, under conditions sufficient to prepare a protected α-O-glycolipid. The second step involves deprotecting the protected α-O-glycolipid under conditions sufficient to prepare the unprotected α-O-glycolipid, wherein the contacting and deprotecting steps are performed in a single vessel. The present invention also provides a one-pot method of preparing an unprotected β-O-glycolipid following the steps for the preparation of the unprotected α-O-glycolipid. | 08-07-2014 |
20140316120 | HAIR GROWTH AND HAIR RESTORATION MATERIAL - Provided is a novel hair growth and hair restoration material having excellent efficacy in hair growth and hair restoration for both men and women, even when the components thereof are at ultra-dilute concentrations; the hair growth and hair restoration material being characterized in containing a steryl glucopyranoside, preferably a cholesteryl glucopyranoside, represented by general formula (I). (In the formula, Z represents a sterol residue from which the hydroxyl group attached to the 3-position of a cyclopentanohydrophenanthrene ring has been removed.) | 10-23-2014 |
20150011739 | TANDEM FACIAL AMPHIPHILES - The invention provides tandem facial amphiphiles for biochemical manipulations and characterization of membrane proteins, such as intrinsic membrane proteins. Members of this new family display favorable behavior with several membrane proteins. These amphiphiles can form relatively small micelles, and small changes in amphiphile chemical structures can result in large changes in their physical properties. The tandem facial amphiphiles can be used to aid the solubilization, isolation, purification, stabilization, crystallization, and/or structural determination of membrane proteins. | 01-08-2015 |
20150057440 | TWO CRYSTAL FORMS OF GINSENOSIDE C-K AND METHOD FOR PREPARING SAME - Provided are ginsenoside C-K polymorphic forms and a method for preparing same. The ginsenoside C-K polymorphic forms are crystal form D and crystal form H. | 02-26-2015 |
20150099870 | Glycosylation Reactions Using Phenyl(trifluoroethyl)iodonium Salts - Provided are methods for the preparation of glycosylation products, including those represented by formula I: | 04-09-2015 |
20150112048 | Novel Ginsenoside Derivative Compounds And The Use Thereof In Protection Against Ischemia/Reperfusion Injury - The present invention provides novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury. | 04-23-2015 |
20150335670 | Medical applications of Notoginsenoside Fc - A method for preparing a platelet aggregation inhibitor, a blood coagulation inhibitor, and a pharmaceutical composition or a food for preventing or treating thrombotic diseases, includes applying notoginsenoside Fc. | 11-26-2015 |
536006000 | Oxygen containing six-membered hetero ring (e.g., oxathiane, etc.) | 10 |
20080275225 | Synthetic Method of 20 (S)-Ginsenoside Rh2 - A synthetic method of 20(s)-ginsenoside Rh2, that is 20(S)-protopanaxdiol-3-O-β-D-glucopyranoside, is comprised of: protecting protopanaxdiol (A1) selectively first to produce monosubstituted protopanaxdiol (A2); and Glycosidating the monosubstituted protopanaxdiol with Glucopyranosyl donor in the presence of Lewis acid catalyst; Deprotecting the product; Then separating and purifying to obtain 20(s)-ginsenoside Rh2. The method is conducted under mild condition at low cost, and affords product with high stereoselectivity, high yield and purity. Therefore, the synthetic method of the present invention is suitable for production on large scale. | 11-06-2008 |
20110054156 | SYNTHESIS OF TIMOSAPONIN BII - The invention provides a synthetic route from sarsasapogenin to timosaponin BII and related compounds. A diketone intermediate is provided, which can advantageously be used for in situ assembly of complex sugar moieties of the desired glycone end product. The diketone compound is then selectively reduced using a borohydride reducing agent to form the desired end product, certain of the end products and intermediates are novel compounds perse. | 03-03-2011 |
20110251379 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS - As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease. | 10-13-2011 |
20120083592 | CONTINUOUS PREPARATION METHOD OF GINSENG GINSENOSIDES AND POLYSACCHARIDES - The present invention provides a continuous preparation method of ginseng ginsenosides and polysaccharides, whereby the ginseng extract liquor and supercritical solvent are poured continuously into a separation tank at 10-30 MPa and 40-60° C. as well as a preset flow rate; so the ginseng extract liquor can be separated in the separation tank to obtain ginsenosides and polysaccharides at different positions of the separation tank. | 04-05-2012 |
20120309947 | METHOD AND SYSTEM FOR CONTINUOUS SEPARATION AND PURIFICATION OF GINSENOSIDES - The present invention provides a method and system for continuous separation and purification of ginsenosides, whereby supercritical fluid technology is used to feed Ginseng extract liquor and supercritical solvent continuously into a separation tank at 20-30 Mpa and 40-60° C., such that ginsenosides can be separated from Ginseng extract liquor; then, ginsenosides are continuously fed to a purifying tank for obtaining highly pure ginsenosides; this system comprising: a holding tank, used to accommodate Ginseng extract liquor; a separation tank, connected with the holding tank, fitted with an electric heater, and used to separate ginsenosides from Ginseng extract liquor; a supercritical fluid vessel, connected with the separation tank to provide supercritical fluid; a high-pressure metering pump, connected between the supercritical fluid vessel and separation tank; a reactant metering pump, connected between the holding tank and separation tank; a precooler, connected between the supercritical fluid vessel and high-pressure metering pump; two preheaters, connected separately between the high-pressure metering pump, reactant metering pump and separation tank; a purifying tank, connected with the separation tank, fitted with an electric heater, and used to purify ginsenosides; two temperature controllers, connected separately with the electric heater in the separation tank and purifying tank. | 12-06-2012 |
20130060013 | Compounds useful for treating neurodegenerative disorders - The present invention provides compounds of formula I: | 03-07-2013 |
20140303359 | Stereoselective Glycosylation Reactions - Disclosed is a method for selective synthesis of 1,2-cis-α-linked glycosides which does not require the use of the specialized protecting group patterns normally employed to control diastereoselectivity. Thioglycoside acceptors can be used, permitting iterative oligosaccharide synthesis. The approach eliminates the need for lengthy syntheses of monosaccharides possessing highly specialized and unconventional protecting group patterns. | 10-09-2014 |
20150065699 | GINSENOSIDE C-K POLYMORPHIC COMPOUNDS AND METHOD FOR PREPARING SAME - Provided are several types of ginsenoside polymorphic substances and a method for preparing same. In particular, new crystal form A, crystal form B, crystal form C, crystal form E, crystal form F, crystal form I, crystal form K, crystal form L, crystal form M, crystal form N, and crystal form O are involved. | 03-05-2015 |
20150105543 | SYNTHESIS - The present invention provides an improved synthesis of a class of steroid saponins. Furthermore, the present invention provides a method of selectively discriminating between the C2 and C3 hydroxyl groups of a mono-glycosylated steroid saponin—a key step in the preparation of this class of compounds. Additionally, the present invention provides a range of steroid saponin derivatives, and methods of making them. | 04-16-2015 |
20150307543 | POLYMORPH - The present invention relates to a new polymorphic form of the compound diosgenyl α-L-rhamnopyranosyl-(1->2)-β-D-glucopyranoside (compound I) and pharmaceutical compositions containing this polymorph | 10-29-2015 |
536600100 | Oxygen containing five-membered hetero ring | 3 |
536600200 | Nitrogen, phosphorus or halogen containing | 1 |
20120059158 | STEROID COMPOUND - A steroid compound of the Formula (1): | 03-08-2012 |
536600300 | Processes of extracting from plant materials | 2 |
20100160616 | NOVEL PROCESS FOR THE EXTRACTION OF FUROSTANOLIC SAPONINS FROM FENUGREEK SEEDS - A novel, commercially viable process for the extraction of high purity (>70%), bioactive furostanolic saponins including protodioscin (>30%), from the seeds of fenugreek ( | 06-24-2010 |
20130090461 | NEW COMPOUND SMILAXCHINOSIDE F - Smilaxchinoside F compound and its separation method are disclosed. The compound has the structure as following. The use of Smilaxchinoside F in the manufacture of a medicine for treating abnormal angiogenesis and its relating diseases is also disclosed. | 04-11-2013 |